Cargando…

Editorial: The Role of Ceramides in Diabetes and Cardiovascular Disease

Detalles Bibliográficos
Autor principal:	Summers, Scott A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994593/ https://www.ncbi.nlm.nih.gov/pubmed/33776946 http://dx.doi.org/10.3389/fendo.2021.667885

Ejemplares similares

The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines
por: Field, Bianca C., et al.
Publicado: (2020)

Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
por: Nicholson, Rebekah J., et al.
Publicado: (2021)

Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
por: Poss, Annelise M., et al.
Publicado: (2020)

Editorial: Cardiovascular Disease and Diabetes
por: Santulli, Gaetano
Publicado: (2019)

The Role of Ceramides in Insulin Resistance
por: Sokolowska, Emilia, et al.
Publicado: (2019)

Editorial: Cardiovascular Diseases Related to Diabetes and Obesity
por: Rajesh, Mohanraj, et al.
Publicado: (2022)

Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification
por: Hilvo, Mika, et al.
Publicado: (2020)

Editorial: Non-coding RNA in diabetes and cardiovascular diseases
por: Macvanin, Mirjana T., et al.
Publicado: (2023)

PMON209 Ceramides Predict Metabolic Response to Metformin in Women with PCOS
por: Sharma, Anu, et al.
Publicado: (2022)

Editorial: The role of metabolic syndrome and disorders in cardiovascular disease
por: Di Pietro, Paola, et al.
Publicado: (2023)

Ceramides in Adipose Tissue
por: Li, Ying, et al.
Publicado: (2020)

Editorial: Cardiovascular diseases related to diabetes and obesity – volume II
por: Young, Jamie L., et al.
Publicado: (2022)

Editorial: Advanced Cardiovascular Imaging in Diabetes
por: Schick, Fritz, et al.
Publicado: (2022)

Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases
por: Raichur, Suryaprakash
Publicado: (2020)

Emerging Roles of Ceramide in Cardiovascular Diseases
por: Shu, Hongyang, et al.
Publicado: (2022)

Ceramides and Sphingosino-1-Phosphate in Obesity
por: Juchnicka, Ilona, et al.
Publicado: (2021)

Editorial: Insulin resistance and cardiovascular disease
por: Stewart, Alan J., et al.
Publicado: (2023)

Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?
por: Mah, Michael, et al.
Publicado: (2021)

Editorial: The Impact of Adipose Tissue Dysfunction on Cardiovascular and Renal Disease
por: Sun, Xiaodong, et al.
Publicado: (2022)

Editorial: The role of oxidative stress and systemic inflammation in diabetes and chronic kidney disease
por: Chanda, Dipanjan, et al.
Publicado: (2023)

Editorial: The effects of circulating non-sex hormones in cardiovascular disease
por: Shan, Su-Kang, et al.
Publicado: (2022)

Editorial: Diabetic renal tubulointerstitial disease
por: Iizuka, Katsumi, et al.
Publicado: (2023)

Adipocyte Ceramides—The Nexus of Inflammation and Metabolic Disease
por: Chaurasia, Bhagirath, et al.
Publicado: (2020)

Editorial: the role of diabetes in the pathophysiology and prognosis of ischemic stroke
por: Zhu, Juehua, et al.
Publicado: (2023)

Ceramides: Nutrient Signals that Drive Hepatosteatosis
por: Summers, Scott A.
Publicado: (2020)

Editorial: Insights in cardiovascular endocrinology: 2023
por: Santulli, Gaetano
Publicado: (2023)

Strong Heart, Low Ceramides
por: Holland, William L., et al.
Publicado: (2018)

Editorial: Endocrine-related cardiovascular diseases: Recent advances in diagnosis and treatment
por: Bhat, Audesh, et al.
Publicado: (2023)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
por: Jiang, Meng, et al.
Publicado: (2019)

Editorial: The impact of adipose tissue dysfunction on cardiovascular and renal disease, Volume II
por: Sun, Xiaodong, et al.
Publicado: (2023)

Role of Leptin in Cardiovascular Diseases
por: Poetsch, Mareike S., et al.
Publicado: (2020)

Editorial: Rising stars in cardiovascular endocrinology 2022
por: Lorenzo, Óscar
Publicado: (2023)

Editorial: The Role of Exosomes in Metabolic and Endocrine Disease
por: Guo, Bei, et al.
Publicado: (2022)

Editorial: Roles and mechanisms of adipokines in metabolic diseases
por: Xie, Liwei, et al.
Publicado: (2023)

Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
por: Blachnio-Zabielska, Agnieszka, et al.
Publicado: (2022)

Editorial: Diabetes and aging
por: Barbosa, Helena Cristina de Lima
Publicado: (2022)

Editorial: Technologies for diabetes
por: Salzano, Giuseppina, et al.
Publicado: (2023)

Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease
por: Li, Chengshun, et al.
Publicado: (2022)

Editorial: The Role of Genetic and Lifestyle Factors in Metabolic Diseases
por: Ahmad, Shafqat, et al.
Publicado: (2019)

Editorial: Mitochondrial Biology and Its Role in Metabolic Diseases
por: Schneider, Jochen G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0jd301josl4v63cporf5lm54m3